Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2013

01.03.2013 | Editorial

Differential diagnosis of major depression and bipolar disorder

verfasst von: Andrea Schmitt, Peter Falkai

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Excerpt

This issue is dedicated to the differential diagnosis of affective disorders with focus on clinical and neuroimaging markers. From a first view, psychosocial dysfunction is mainly associated with schizophrenia. However, Bottlender et al. [1] analyzed the association between psychosocial function and psychopathology in schizophrenia, schizoaffective and affective disorder. For all diagnostic groups, they found higher levels of psychopathology to be associated with higher levels of psychosocial dysfunction in various domains, highlighting the importance of symptom remission in major psychiatric disorders. Major depression and bipolar disorder are known to have a high heritability. Serretti et al. [2] investigated the impact of a family history on clinical and socio-demographic variables. They found a positive family history more common in bipolar patients than in major depression plus an association with anxiety disorders and age of onset in both diseases. However, hypomania is frequent in patients with major depressive episodes, and the DSM-IV concept of hypomanic episodes should be revised [3]. …
Literatur
1.
Zurück zum Zitat Bottlender R, Strauss A, Möller H-J (2012) Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0335-6 PubMed Bottlender R, Strauss A, Möller H-J (2012) Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0335-6 PubMed
2.
Zurück zum Zitat Serretti A, Chiesa A, Calati R, Linotte S, Sentissi O, Papageorgiou K, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D (2012) Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0322-y Serretti A, Chiesa A, Calati R, Linotte S, Sentissi O, Papageorgiou K, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D (2012) Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0322-y
3.
Zurück zum Zitat Angst J, Gamma A, Bowden CL et al (2012) Diagnostic criteria for biolarity based on and international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 262:3–11PubMedCrossRef Angst J, Gamma A, Bowden CL et al (2012) Diagnostic criteria for biolarity based on and international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 262:3–11PubMedCrossRef
4.
Zurück zum Zitat Pinto C, Souza RP, Lioult D et al (2011) Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behavior. Eur Arch Psychiatry Clin Neurosci 261:533–538PubMedCrossRef Pinto C, Souza RP, Lioult D et al (2011) Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behavior. Eur Arch Psychiatry Clin Neurosci 261:533–538PubMedCrossRef
5.
Zurück zum Zitat Kishi T, Yoshimura R, Fukuo Y, Okochi T, Matsunaga S, Umene-Nakano W, Nakamura J, Serretti A, Correll CU, Kane JM, Iwata N (2012) The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0337-4 PubMed Kishi T, Yoshimura R, Fukuo Y, Okochi T, Matsunaga S, Umene-Nakano W, Nakamura J, Serretti A, Correll CU, Kane JM, Iwata N (2012) The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0337-4 PubMed
6.
Zurück zum Zitat Gos T, Steiner J, Bielau H et al (2012) Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Arch Psychiatry Clin Neurosci 262:647–655CrossRef Gos T, Steiner J, Bielau H et al (2012) Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Arch Psychiatry Clin Neurosci 262:647–655CrossRef
7.
Zurück zum Zitat Grotegerd D, Suslow T, Bauer J, Ohrmann P, Arolt V, Stuhrmann A, Heindel W, Kugel H, Dannlowski U (2012) Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0329-4 PubMed Grotegerd D, Suslow T, Bauer J, Ohrmann P, Arolt V, Stuhrmann A, Heindel W, Kugel H, Dannlowski U (2012) Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0329-4 PubMed
8.
Zurück zum Zitat Molina V, Martin C, Ballestros A et al (2011) Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics. Arch Psychiatry Clin Neurosci 261:407–416CrossRef Molina V, Martin C, Ballestros A et al (2011) Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics. Arch Psychiatry Clin Neurosci 261:407–416CrossRef
9.
Zurück zum Zitat McFarland J, Cannon DM, Schmidt H, Ahmed M, Hehir S, Emsell L, Barker G, McCarthy P, Elliott MA, McDonald C (2012) Association of grey matter volume deviation with insight impairment in first-episode affective and non-affective psychosis. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0333-8 PubMed McFarland J, Cannon DM, Schmidt H, Ahmed M, Hehir S, Emsell L, Barker G, McCarthy P, Elliott MA, McDonald C (2012) Association of grey matter volume deviation with insight impairment in first-episode affective and non-affective psychosis. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0333-8 PubMed
10.
Zurück zum Zitat Escribà-Agüir V, Royo-Marqués M, Artazcoz L, Romito P, Ruiz-Pérez I (2012) Longitudinal study of depression and health status in pregnant women: incidence, course and predictive factors. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0336-5 PubMed Escribà-Agüir V, Royo-Marqués M, Artazcoz L, Romito P, Ruiz-Pérez I (2012) Longitudinal study of depression and health status in pregnant women: incidence, course and predictive factors. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0336-5 PubMed
11.
Zurück zum Zitat da Silva SA, Scazufca M, Menezes PR (2012) Population impact of depression on functional disability in elderly: results from “São Paulo Ageing & Health Study” (SPAH). Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0345-4 PubMed da Silva SA, Scazufca M, Menezes PR (2012) Population impact of depression on functional disability in elderly: results from “São Paulo Ageing & Health Study” (SPAH). Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0345-4 PubMed
12.
Zurück zum Zitat Guimaraes Barbosa I, Barreto Huguet R, Amaral Mendonca V et al (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Arch Psychiatry Clin Neurosci 261:139–143CrossRef Guimaraes Barbosa I, Barreto Huguet R, Amaral Mendonca V et al (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Arch Psychiatry Clin Neurosci 261:139–143CrossRef
13.
Zurück zum Zitat Barbosa IG, Rocha NP, Bauer ME, de Miranda AS, Huguet RB, Reis HJ, Zunszain PA, Horowitz MA, Pariante CM, Teixeira AL (2012) Chemokines in bipolar disorder: trait or state? Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0327-6 PubMed Barbosa IG, Rocha NP, Bauer ME, de Miranda AS, Huguet RB, Reis HJ, Zunszain PA, Horowitz MA, Pariante CM, Teixeira AL (2012) Chemokines in bipolar disorder: trait or state? Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0327-6 PubMed
14.
Zurück zum Zitat Kristensen D, Bauer J, Hageman I, Jorgensen MB (2011) Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Arch Psychiatry Clin Neurosci 261:425–432CrossRef Kristensen D, Bauer J, Hageman I, Jorgensen MB (2011) Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Arch Psychiatry Clin Neurosci 261:425–432CrossRef
15.
Zurück zum Zitat Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A (2011) Clinically favourable effects of ketamine as an anesthetic for electroconvulsive therapy: a retrospective study. Arch Psychiatry Clin Neurosci 261:575–582CrossRef Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A (2011) Clinically favourable effects of ketamine as an anesthetic for electroconvulsive therapy: a retrospective study. Arch Psychiatry Clin Neurosci 261:575–582CrossRef
16.
Zurück zum Zitat van Waarde JA, van Oudheusden LJB, Verwey B, Giltay EJ, van der Mast RC (2012) Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0342-7 PubMed van Waarde JA, van Oudheusden LJB, Verwey B, Giltay EJ, van der Mast RC (2012) Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0342-7 PubMed
Metadaten
Titel
Differential diagnosis of major depression and bipolar disorder
verfasst von
Andrea Schmitt
Peter Falkai
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2013
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-013-0396-1

Weitere Artikel der Ausgabe 2/2013

European Archives of Psychiatry and Clinical Neuroscience 2/2013 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.